A Content Analysis of Problematic Gambling Prevention Interventions in the United States.

Gambling revenue in the United States is at all-time highs while recent and forthcoming legislation relaxes constraints on casino gaming, sports betting, and fantasy sports betting. Increased gambling will result in increased problematic gambling, highlighting the need to study the impact of our problematic gambling prevention interventions. To address this, we conducted a content analysis of problematic gambling prevention messages in the U.

Adults with alcohol use disorder may overreport dietary intake using the 1-year Diet History Questionnaire II.

Minimal recent research explores how alcohol use disorder (AUD) affects dietary intake during periods of alcohol consumption. Therefore, we aimed to assess the feasibility and utility of a computerized food frequency questionnaire, the Diet History Questionnaire II (DHQ II), to quantify dietary intake in adults with AUD. Participants were adult men and women seeking treatment for AUD at the National Institutes of Health Clinical Center.

Quantifying the imprecision of energy intake of humans to compensate for imposed energetic errors: A challenge to the physiological control of human food intake.

To assess the precision of the biological control of energy intake we performed a systematic review of studies that measured acute changes in human food intake in response to energetic errors. The imposed errors were grouped into the following categories of studies: alternate day fasting, changes in diet composition, exercise, meal skipping, overfeeding, energy substitutes, underfeeding and changes in portion size. Seven hundred thirty-nine studies published between 1980 and 2017 were identified from which the data from 592 groups from 200 studies were extracted and subjected to analysis consisting of a total of 13,203 participants.

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor.

Background: Ivacaftor is the first cystic fibrosis transmembrane conductance regulator (CFTR) modulator demonstrating clinical benefit in patients with cystic fibrosis (CF). As ivacaftor is intended for chronic, lifelong use, understanding long-term effects is important for patients and healthcare providers.

Objective: This ongoing, observational, postapproval safety study evaluates clinical outcomes and disease progression in ivacaftor-treated patients using data from the US and the UK CF registries following commercial availability.

Lack of negative autocorrelations of daily food intake on successive days challenges the concept of the regulation of body weight in humans.

According to most theories, the amount of food consumed on one day should be negatively related to intake on subsequent days. Several studies have observed such a negative correlation between the amount consumed on one day and the amount consumed two to four days later. The present study attempted to replicate this observation by re-examining data from a previous study where all food ingested over a 30-day observation period was measured.